21 May 2025 · Sharing what has been learnt so far from the national safer use of time critical medicines programme, including improvement interventions. 1 July 2025.
8 May 2025 · An SPS Quality Assurance (QA) bite size learning event on deviation investigation and establishing root causes in pharmacy aseptic services. 27 June 2025.
30 April 2025 · Discussion about implementing biosimilar insulin in primary care: key considerations, hints, and tips for systems planning the transition. 10 June 2025.
9 April 2025 · An update supporting implementation of biosimilar and key generic medicines for aflibercept, golimumab, nilotinib and ferric carboxymaltose.
26 March 2025 · Discussion of key current medication safety challenges within healthcare with a focus on the safe use of insulin; inspiring partnership across the system.
4 March 2025 · A consultant pharmacist used case studies to illustrate a patient-centered approach to deprescribing in patients with problematic polypharmacy.